News Roche pays $1.7 billion for cancer specialist Ignyta Roche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta.
News After surging on lung cancer data, Ignyta looks to raise $16... San Diego based biotech firm Ignyta is capping off a week of success with a public stock offering t
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
